Summary

Interbody Fusion Cages Market – Scope of Report
TMR’s report on the global interbody fusion cages market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global interbody fusion cages market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global interbody fusion cages market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the interbody fusion cages market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global interbody fusion cages market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global interbody fusion cages market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global interbody fusion cages market.

The report delves into the competitive landscape of the global interbody fusion cages market. Key players operating in the global interbody fusion cages market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global interbody fusion cages market profiled in this report.

Key Questions Answered in Global interbody fusion cages Market Report
• What is the sales/revenue generated by interbody fusion cages across all regions during the forecast period?
• What are the opportunities in the global interbody fusion cages market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Interbody Fusion Cages Market – Research Objectives and Research Approach
The comprehensive report on the global interbody fusion cages market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global interbody fusion cages market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global interbody fusion cages market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Interbody Fusion Cages Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Interbody Fusion Cages Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Regulatory Scenario by Region/Globally
5.2. Key Industry Events (Key Mergers & Acquisitions )
5.3. Disease Epidemiology
5.4. COVID-19 Impact Analysis
6. Global Interbody Fusion Cages Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Cervical
6.3.2. Lumbar
6.3.3. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Interbody Fusion Cages Market Analysis and Forecast, by Material
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Material, 2017–2031
7.3.1. Titanium
7.3.2. Polyetheretherketone (PEEK)
7.3.3. Others
7.4. Market Attractiveness Analysis, by Material
8. Global Interbody Fusion Cages Market Analysis and Forecast, by Product
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Product, 2017–2031
8.3.1. Expandable Cages
8.3.2. Static Cages
8.4. Market Attractiveness Analysis, by Product
9. Global Interbody Fusion Cages Market Analysis and Forecast, by Indication
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Indication, 2017–2031
9.3.1. Degenerative Disc Disease
9.3.2. Spondylolisthesis
9.3.3. Spinal Tumors or Masse
9.3.4. Spinal Stenosis
9.3.5. Others
9.4. Market Attractiveness Analysis, by Indication
10. Global Interbody Fusion Cages Market Analysis and Forecast, by End-user
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Clinics & Orthopedic Centers
10.4. Market Attractiveness Analysis, by End-user
11. Global Interbody Fusion Cages Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017–2031
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Interbody Fusion Cages Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. Cervical
12.2.2. Lumbar
12.2.3. Others
12.3. Market Value Forecast, by Material , 2017–2031
12.3.1. Titanium
12.3.2. Polyetheretherketone (PEEK)
12.3.3. Others
12.4. Market Value Forecast, by Product, 2017–2031
12.4.1. Expandable Cages
12.4.2. Static Cages
12.5. Market Value Forecast, by Indication, 2017–2031
12.5.1. Degenerative Disc Disease
12.5.2. Spondylolisthesis
12.5.3. Spinal Tumors or Masse
12.5.4. Spinal Stenosis
12.5.5. Others
12.6. Market Value Forecast, by End-user, 2017–2031
12.6.1. Hospitals
12.6.2. Ambulatory Surgical Centers
12.6.3. Clinics & Orthopedic Centers
12.7. Market Value Forecast, by Country, 2017–2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Type
12.8.2. By Material
12.8.3. By Product
12.8.4. By Indication
12.8.5. By End-user
12.8.6. By Country
13. Europe Interbody Fusion Cages Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. Cervical
13.2.2. Lumbar
13.2.3. Others
13.3. Market Value Forecast, by Material , 2017–2031
13.3.1. Titanium
13.3.2. Polyetheretherketone (PEEK)
13.3.3. Others
13.4. Market Value Forecast, by Product, 2017–2031
13.4.1. Expandable Cages
13.4.2. Static Cages
13.5. Market Value Forecast, by Indication, 2017–2031
13.5.1. Degenerative Disc Disease
13.5.2. Spondylolisthesis
13.5.3. Spinal Tumors or Masse
13.5.4. Spinal Stenosis
13.5.5. Others
13.6. Market Value Forecast, by End-user, 2017–2031
13.6.1. Hospitals
13.6.2. Ambulatory Surgical Centers
13.6.3. Clinics & Orthopedic Centers
13.7. Market Value Forecast, by Country/Sub-region, 2017–2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Type
13.8.2. By Material
13.8.3. By Product
13.8.4. By Indication
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Interbody Fusion Cages Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
14.2.1. Cervical
14.2.2. Lumbar
14.2.3. Others
14.3. Market Value Forecast, by Material , 2017–2031
14.3.1. Titanium
14.3.2. Polyetheretherketone (PEEK)
14.3.3. Others
14.4. Market Value Forecast, by Product, 2017–2031
14.4.1. Expandable Cages
14.4.2. Static Cages
14.5. Market Value Forecast, by Indication, 2017–2031
14.5.1. Degenerative Disc Disease
14.5.2. Spondylolisthesis
14.5.3. Spinal Tumors or Masse
14.5.4. Spinal Stenosis
14.5.5. Others
14.6. Market Value Forecast, by End-user, 2017–2031
14.6.1. Hospitals
14.6.2. Ambulatory Surgical Centers
14.6.3. Clinics & Orthopedic Centers
14.7. Market Value Forecast, by Country/Sub-region, 2017–2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Type
14.8.2. By Material
14.8.3. By Product
14.8.4. By Indication
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Interbody Fusion Cages Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017–2031
15.2.1. Cervical
15.2.2. Lumbar
15.2.3. Others
15.3. Market Value Forecast, by Material , 2017–2031
15.3.1. Titanium
15.3.2. Polyetheretherketone (PEEK)
15.3.3. Others
15.4. Market Value Forecast, by Product, 2017–2031
15.4.1. Expandable Cages
15.4.2. Static Cages
15.5. Market Value Forecast, by Indication, 2017–2031
15.5.1. Degenerative Disc Disease
15.5.2. Spondylolisthesis
15.5.3. Spinal Tumors or Masse
15.5.4. Spinal Stenosis
15.5.5. Others
15.6. Market Value Forecast, by End-user, 2017–2031
15.6.1. Hospitals
15.6.2. Ambulatory Surgical Centers
15.6.3. Clinics & Orthopedic Centers
15.7. Market Value Forecast, by Country/Sub-region, 2017–2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Type
15.8.2. By Material
15.8.3. By Product
15.8.4. By Indication
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Interbody Fusion Cages Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Type, 2017–2031
16.2.1. Cervical
16.2.2. Lumbar
16.2.3. Others
16.3. Market Value Forecast, by Material , 2017–2031
16.3.1. Titanium
16.3.2. Polyetheretherketone (PEEK)
16.3.3. Others
16.4. Market Value Forecast, by Product, 2017–2031
16.4.1. Expandable Cages
16.4.2. Static Cages
16.5. Market Value Forecast, by Indication, 2017–2031
16.5.1. Degenerative Disc Disease
16.5.2. Spondylolisthesis
16.5.3. Spinal Tumors or Masse
16.5.4. Spinal Stenosis
16.5.5. Others
16.6. Market Value Forecast, by End-user, 2017–2031
16.6.1. Hospitals
16.6.2. Ambulatory Surgical Centers
16.6.3. Clinics & Orthopedic Centers
16.7. Market Value Forecast, by Country/Sub-region, 2017–2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Type
16.8.2. By Material
16.8.3. By Product
16.8.4. By Indication
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (by tier and size of companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
17.3.1. Medtronic plc
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Johnson & Johnson
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Stryker Corporation
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Zimmer Biomet
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. B. Braun Melsungen AG
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. NuVasive, Inc.
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Alphatec Holdings, Inc.
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. LASAK s.r.o.
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Xtant Medical Holdings, Inc.
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. Spineology, Inc.
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. Financial Overview
17.3.10.4. SWOT Analysis
17.3.10.5. Strategic Overview